Profile
TECX VRTX REGN ALNY SGEN ARGX
Company Name Tectonic Therapeutic, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $402.39M $117.98B $60.26B $43.28B $43.15B $34.40B
Employees 0.05K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Alise S. Reicin Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
TECX VRTX REGN ALNY SGEN ARGX
Quant Rating Score 3 2 4 1 3 2
Quant Rating Neutral Sell Buy Strong Sell Neutral Sell
Trading
TECX VRTX REGN ALNY SGEN ARGX
Last Close $21.44 $464.2 $547.96 $311.12 $228.74 $555.96
High 52 $54.84 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $14.67 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -60.9 % -10.17 % -54.4 % -6.26 % 0 % -17.24 %
Price vs. 52 Week Low 46.15 % 17.03 % 13.47 % 38.53 % 0 % 20.6 %
Total Return
TECX VRTX REGN ALNY SGEN ARGX
1 Month Return -0.19 % 2.95 % 4.84 % 0.76 % 0 % 0.86 %
3 Month Return 22.1 % -4.46 % -0.24 % 34.98 % 0 % -5.38 %
6 Month Return -48.98 % 11.33 % -20.96 % 24.87 % 0 % -15.74 %
9 Month Return -39.44 % -6.92 % -45.11 % 4.84 % 0 % 2.23 %
YTD Return -53.56 % 15.27 % -23.07 % 32.22 % 0 % -9.6 %
1 Year Return 24.72 % -5.07 % -49.96 % 24.53 % 0 % 17.84 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TECX VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -352.98 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
TECX VRTX REGN ALNY SGEN ARGX
Asset Growth 288.09 % -0.87 % 36.55 %
Gross Profit Growth -166.61 % 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth -35.63 % -93.69 % 128.87 %
Net Income Growth -35.4 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share 79.53 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share 78.6 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -192.08 % 33.84 % 938.02 %
Operating Income Growth -29.94 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -45.23 % -113.93 % 80.31 %
Operating 3 Year CFG 74.65 % -118.65 % 88.36 %
Operating 5 Year CFG 76.49 % -131.3 % -135.21 %
Operating 10 Year CFG -318.85 % 12.43 % -64 %
EPS Growth 41.07 % -114.8 % 369.77 %
EPS Diluted Growth 40.76 % -114.97 % 347.67 %
Book Value Per Share 85.35 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share -65.06 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share -79.62 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 648.13 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -23.95 % 116.42 % 95.27 %
Free Cash Flow Growth -44.62 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
TECX VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -18.63 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -30.94 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -21.02 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 92.61 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -2454.18 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 0.12 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -3.76 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -3.68 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 1784.89 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 97.64 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -2454.18 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -6.38 -93.78 19.95 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -5.72 -120.39 15.32 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -5.72 -120.39 15.32 -954.11 -93.1 -526.76
Income Statement (TTM)
TECX VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.06B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -6.83 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
TECX VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.14B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.15B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
TECX VRTX REGN ALNY SGEN ARGX
Net Income $-0.06B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.76
AARD Aardvark Therapeutics, Inc. Common Stock 11.61
ABCL AbCellera Biologics Inc. 3.94
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.95
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.31
ABPWW 0.0224
ABSI Absci Corporation 2.57
ABUS Arbutus Biopharma Corporation 3.13
ABVC ABVC BioPharma, Inc. 3.57
ABVX Abivax SA American Depositary Shares 8.85
ACAD ACADIA Pharmaceuticals Inc. 22.01
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7624
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.64
ACIU AC Immune SA 2.05
ETFs With Exposure to TECX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00862 218.82
VTI Vanguard Total Stock Market Index Fund 0 306.1
IBB iShares Biotechnology ETF 0.02581 129.05
IWN iShares Russell 2000 Value ETF 0.01518 161.48
IWO iShares Russell 2000 Growth ETF 0.00277 287.06
BIB ProShares Ultra Nasdaq Biotechnology 0.0309827 48.6
VXF Vanguard Extended Market Index Fund 0 194.45
HDG ProShares Hedge Replication ETF 0.00128336 49.8863
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.77 21.065
UWM ProShares Ultra Russell2000 0.00712381 38.6
VTHR Vanguard Russell 3000 Index Fund 0 274.6
IWC iShares Micro-Cap ETF 0.06225 130.97
DWAS Invesco DWA SmallCap Momentum ETF 0.279 83.39
URTY ProShares UltraPro Russell2000 0.00577481 40.77
VTWV Vanguard Russell 2000 Value Index Fund 0.01 142.44
ISCB iShares Morningstar Small-Cap ETF 0.0023 58.9594
VTWG Vanguard Russell 2000 Growth Index Fund 0 209.8
VTWO Vanguard Russell 2000 Index Fund 0.01 88.49
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 41.9
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 104.11
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.09
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.84
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.83
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.84
DFAU Dimensional US Core Equity Market ETF 0.000003721 42.67
IBBQ Invesco Nasdaq Biotechnology ETF 0.045 21.82
DFUS Dimensional U.S. Equity ETF 0.00033961 67.43
DFAT Dimensional U.S. Targeted Value ETF 0.00010231 54.7
DFAS Dimensional U.S. Small Cap ETF 0.0000200191 64.32
DFAC Dimensional U.S. Core Equity 2 ETF 0.00019011 36.11
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.04524 5.5
VTSAX Vanguard Total Stock Market Index Fund 0 149.02
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.04524 6.3725
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 147.58
VITSX Vanguard Total Stock Market Index Fund 0 149.04
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.04524 6.347
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 147.59
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.04524 4.763
JKJ iShares Morningstar Small-Cap ETF 0.0023 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 52.69
DCOR Dimensional ETF Trust 0.00082109 67.3
VEMPX Vanguard Extended Market Index InstlPlus 0 364.19
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 279.58
RSSL Global X Funds 0.01 85.94
RFLR Innovator ETFs Trust 0.03 25.655
Unlock